U
Uma Valeti
Researcher at University of Minnesota
Publications - 20
Citations - 1097
Uma Valeti is an academic researcher from University of Minnesota. The author has contributed to research in topics: Coronary artery disease & Heart failure. The author has an hindex of 9, co-authored 20 publications receiving 917 citations. Previous affiliations of Uma Valeti include Medical University of South Carolina & Stanford University.
Papers
More filters
Journal ArticleDOI
The CT-STAT (coronary computed tomographic angiography for systematic triage of acute chest pain patients to treatment) trial
James A. Goldstein,Kavitha Chinnaiyan,Aiden Abidov,Stephan Achenbach,Daniel S. Berman,Sean W. Hayes,Udo Hoffmann,John R. Lesser,Issam Mikati,Brian J. O'Neil,Leslee J. Shaw,Michael Y.H. Shen,Uma Valeti,Gilbert L. Raff +13 more
TL;DR: In emergency department acute, low-risk chest pain patients, the use of CCTA results in more rapid and cost-efficient safe diagnosis than rest-stress MPI.
Journal ArticleDOI
Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage
Erik B. Schelbert,Kayla Piehler,Karolina M. Zareba,James C. Moon,Martin Ugander,Daniel Messroghli,Uma Valeti,Chung-Chou H. Chang,Sanjeev G. Shroff,Javier Díez,Christopher A. Miller,Matthias Schmitt,Peter Kellman,Javed Butler,Mihai Gheorghiade,Timothy C. Wong +15 more
TL;DR: MF measured by ECV is associated with hospitalization for heart failure, death, or both and may represent a principal phenotype of cardiac vulnerability that improves risk stratification.
Journal ArticleDOI
Guideline for minimizing radiation exposure during acquisition of coronary artery calcium scans with the use of multidetector computed tomography: A report by the Society for Atherosclerosis Imaging and Prevention Tomographic Imaging and Prevention Councils in collaboration with the Society of Cardiovascular Computed Tomography
Szilard Voros,Juan J. Rivera,Daniel S. Berman,Ron Blankstein,Matthew J. Budoff,Ricardo C. Cury,Milind Y. Desai,Damini Dey,Sandra S. Halliburton,Harvey S. Hecht,Khurram Nasir,Raul D. Santos,Michael D. Shapiro,Allen J. Taylor,Uma Valeti,Phillip M. Young,Gaby Weissman +16 more
TL;DR: In this paper, the authors present guidelines for low-radiation CAC scans for intermediate risk, asymptomatic subjects without previous coronary disease, which can be influenced by careful attention to image acquisition.
Journal ArticleDOI
Selective Referral Using CCTA Versus Direct Referral for Individuals Referred to Invasive Coronary Angiography for Suspected CAD: A Randomized, Controlled, Open-Label Trial
Hyuk Jae Chang,Fay Y. Lin,Dan Gebow,Hae Young An,Daniele Andreini,Ravi Bathina,Andrea Baggiano,Virginia Beltrama,Rodrigo Cerci,Eui-Young Choi,Jung Hyun Choi,So-Yeon Choi,Namsik Chung,Jason H. Cole,Joon Hyung Doh,Sang Jin Ha,Ae Young Her,Cezary Kępka,Jang Young Kim,Jin Won Kim,Sang Wook Kim,Woong Kim,Gianluca Pontone,Uma Valeti,Todd C. Villines,Yao Lu,Amit Kumar,Iksung Cho,Ibrahim Danad,Donghee Han,Donghee Han,Ran Heo,Sang Eun Lee,Ji Hyun Lee,Ji Hyun Lee,Hyung Bok Park,Ji Min Sung,David Leflang,Joseph Zullo,Leslee J. Shaw,James K. Min +40 more
TL;DR: In stable patients with suspected CAD who are eligible for ICA, the comparable 1-year major adverse cardiovascular events rates following a selective referral and direct referral strategy suggests that both diagnostic approaches are similarly effective.
Journal ArticleDOI
Myocardial Damage Detected by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Is Associated With Subsequent Hospitalization for Heart Failure
Timothy C. Wong,Kayla Piehler,Karolina M. Zareba,Kathie Lin,Ashley Phrampus,Agam Patel,James C. Moon,Martin Ugander,Uma Valeti,Jonathan E. Holtz,Bo Fu,Chung-Chou H. Chang,Michael A. Mathier,Peter Kellman,Javed Butler,Mihai Gheorghiade,Erik B. Schelbert +16 more
TL;DR: The presence and extent of LGE is associated with vulnerability for HHF, including higher risks of HHF across the spectrum of heart failure stage and LVEF, and may enhance both clinical and research efforts to reduce HHF through targeted treatment.